High cyclin B1 expression is associated with poor survival in breast cancer. - Wikidata - wikimedia - TriplyDB

High cyclin B1 expression is associated with poor survival in breast cancer.

High cyclin B1 expression is associated with poor survival in breast cancer.

http://www.wikidata.org/entity/Q37160662

about

Data integration workflow for search of disease driving genes and genetic variants Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells Upregulation of Cyclin B1 by miRNA and its implications in cancer Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression A retro-inverso cell-penetrating peptide for siRNA delivery.Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors Expression of Hsp90α and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.Mitotic chromosomal instability and cancer: mouse modelling of the human disease.Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation The history and future of targeting cyclin-dependent kinases in cancer therapy.Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.GOBO: gene expression-based outcome for breast cancer online Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.Cyclin b1 suppresses colorectal cancer invasion and metastasis by regulating e-cadherin PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors.Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth.Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors.Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer Transcriptional control of the proliferation cluster by the tumor suppressor p53.IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.Prognostic role of cyclin B1 in solid tumors: a meta-analysis.The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division Prognostic value of proliferation markers expression in breast cancer.Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.Identifying differentially expressed genes in cancer patients using a non-parameter Ising model.Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest.Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.

P2860

Q21135492-6C7B47E6-3812-4C10-B164-9CF7F6F4ACEF Q24300739-E6CB76E6-37BF-4AE1-81B2-6F6E0C08F12A Q24630059-21E77CAF-5FE2-4079-836F-4F04B031644B Q26827580-9EF50543-D532-47EF-AF18-DB2ED3F522BB Q30838103-9EC069E9-D87E-418A-8786-E04DAB63A6B3 Q30847307-C50BBF2A-D0F8-479A-981B-736FEC9C7DB0 Q33483633-CBF1A4EC-9626-493A-ACD1-8D4B2F049A97 Q33582975-0B342C31-08BC-48B5-8664-E7FD60A9C39C Q33594076-3572B098-1584-475D-90BF-2E8EB68B923E Q33627135-72688935-E930-41E4-9597-578FD5C3430B Q33627215-C31240DA-7EF0-4235-BDCB-078DCC9F5D81 Q33672809-78DD06DB-FCE6-47A6-BB5A-23FF50692DF9 Q33926467-EF1471EB-8650-42C6-AE15-95E653A12B25 Q34113332-9F6BF5F3-FEC5-4C4E-8C2A-835C6CAC0054 Q34460347-33F8C3A8-2057-45D9-AB3A-FA9A31543162 Q34506613-A3A85089-8253-4C50-99AB-B3E019BA13BE Q34704073-64FA0330-969C-40E3-BD43-556E82ADD64D Q35003431-A3945FF6-4828-4639-9912-7574B2EDC5DA Q35566231-35C91C69-0470-42A4-969F-CC20F7D1AEBF Q35592447-9ECE9B0B-3307-498D-A62B-3DE53D86CE6B Q36140798-4B25BA28-0AAB-42E7-9542-358D3E70E3BF Q36255950-1DE8FD05-C6B9-4766-988F-E3C49375FAED Q36619756-2FA052B3-D9B9-4C3C-A4D2-DD8734749F33 Q36742577-C0E06846-6FA2-4DE1-87B4-53379D00112A Q36998212-B4153042-172D-40AB-8EEC-7B5EDA4990CE Q37040328-B4E6570A-622C-40BD-BE02-A2D7E6EE7844 Q37521419-0A9F59B8-74DB-4854-A1B1-7381719C4639 Q37630882-B4F890E3-39B0-44C2-9129-70D936E4CFDA Q37636710-BBB738CD-D234-4D7A-84AE-EC31A897879A Q37660051-3EB94CDD-0884-4435-9805-7A050F87AD85 Q37709089-15B3F537-9AA6-4716-9460-E3E02C1309E2 Q37709250-2158B3BD-7673-4D2C-82B4-D2617C192210 Q38269417-CF4F2959-E9BA-46DF-A554-68B8ABF499B7 Q41134618-2C75EFB3-B8EA-4332-88E7-9A270EB99124 Q42153175-FED242BA-6906-4E27-8B1F-BFD0060AC642 Q43692538-935E4D56-1074-4799-AF0F-9DB7AEBC06E2 Q44514078-3EBECAFF-DBA2-47A0-A8DF-9586F11E71F1 Q44959102-A82416B2-0141-4B59-AD24-6C1FD2BB06AC Q47289183-6535F022-2F67-42F2-8AEB-71B2BFD8F0F5 Q48693665-26AFE0D6-74D1-4885-A9EF-5876F8BEB4F1

P2860

High cyclin B1 expression is associated with poor survival in breast cancer.

http://www.wikidata.org/entity/Q37160662

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High cyclin B1 expression is associated with poor survival in breast cancer.

@en

High cyclin B1 expression is associated with poor survival in breast cancer.

@nl

type

label

High cyclin B1 expression is associated with poor survival in breast cancer.

@en

High cyclin B1 expression is associated with poor survival in breast cancer.

@nl

prefLabel

High cyclin B1 expression is associated with poor survival in breast cancer.

@en

High cyclin B1 expression is associated with poor survival in breast cancer.

@nl

P1433

Q37160662-4EF48DC4-00F9-4B43-BBCE-C5600A6E4367

P1476

Q37160662-4A16FE60-8898-4B35-A085-EDFF899DA711

P2093

Q37160662-025A7374-CB1B-419F-B7EA-AA146E2DCD78

Q37160662-075A491E-923C-4B2B-A0F1-F861728FE38B

Q37160662-51D01E6E-5EB8-4491-B175-4E979DF6E015

Q37160662-EB4C3A12-7653-4D34-9B47-9CE7538FE6AA

Q37160662-F150F697-15F7-4489-821E-4A6B7446B888

P2860

Q37160662-06F969BC-F1CD-4A20-B257-981A6C374835

Q37160662-18700DDC-0563-41FA-85F1-FB85D20AAD54

Q37160662-19F33832-8B5E-424C-9335-41F98F940690

Q37160662-1C6ADB03-22B3-4808-9248-325D95A38643

Q37160662-20FBE4D1-44C5-4CBF-8D66-FD0D565DF64A

Q37160662-25739521-3B10-4A59-81F6-CDA5DF8EE605

Q37160662-511914CE-1440-4C13-A296-40795309680F

Q37160662-531CF4B0-B1F8-4107-B551-58AD4AC926B6

Q37160662-539C3EA8-35D7-4E92-9658-5A61BCE054D7

Q37160662-5B863AE0-FF0C-4F8B-874E-F86DB1048BBA

P2888

Q37160662-D04B2875-119C-4DC6-AC0E-BFA6EC1B8DF7

P304

Q37160662-51668385-B9B3-4C3F-B61A-777BAE0CE002

P31

Q37160662-B23CCBD6-FEFE-475A-9775-2DD976B49F53

P356

Q37160662-484C9EEF-2C76-4EB1-84C0-D5F8F85CE36E

P407

Q37160662-23D9D8A9-1ABB-4C78-80B2-2A16BBD3AFB0

P433

Q37160662-4285828E-BE03-426A-916B-CB24337E8223

P478

Q37160662-9F7F657C-2131-475B-9C43-36DA98CDBB02

P50

Q37160662-2982BAD1-4836-4140-9529-33BCAA150942

Q37160662-C011BB31-9665-4E2C-B96D-EF3004D07702

P577

Q37160662-59A2A74F-6344-4896-86AC-810FA43CC3CC

P5875

Q37160662-9AF87C4D-D21C-4A34-954F-A154DE2B49DA

P698

Q37160662-F81D1F41-ECA9-49EB-8FE1-DD823E098420

P932

Q37160662-8E448889-C9A7-480A-B3CE-3D0DA22F0969

P356

P1433

British Journal of Cancer

P1476

High cyclin B1 expression is associated with poor survival in breast cancer.

@en

P2093

A Tamminen

http://www.w3.org/2001/XMLSchema#string

K Aaltonen

http://www.w3.org/2001/XMLSchema#string

K Aittomäki

http://www.w3.org/2001/XMLSchema#string

P Heikkilä

http://www.w3.org/2001/XMLSchema#string

R-M Amini

http://www.w3.org/2001/XMLSchema#string

P2860

p53 regulates a G2 checkpoint through cyclin B1

Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication

Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis

Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

P2888

P304

1055-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604874

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Heli Nevanlinna

P577

2009-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24207875

http://www.w3.org/2001/XMLSchema#string

P698

19293801

http://www.w3.org/2001/XMLSchema#string

P932

2669992

http://www.w3.org/2001/XMLSchema#string